Lawsoniaside hinders the growth of amyloid-β42 fibrils. References: Dhouafli Z, Leri M, Bucciantini M, Stefani M, Gadhoumi H, Mahjoub B, Ben Jannet H, Guillard J, Tounsi MS, Ksouri R, Hayouni EA. A new purified Lawsoniaside remodels amyloid-β(42) fibrillation into a less toxic and non-amyloidogenic pathway. Int J Biol Macromol. 2018 Jul 15;114:830-835. doi: 10.1016/j.ijbiomac.2018.04.005. Epub 2018 Apr 4. PubMed PMID: 29626601.

纯度：≥98%

CAS：116964-02-4